Evidence map›Paper›PMID 42280174›Full record

ArticleMolecules (Basel, Switzerland)2026

Grigory V Mokrov, Svetlana A Litvinova, Valentina E Biryukova, Tatiana A Voronina, Sergey V Shorunov, Alexey G Rebeko, Tatiana Yu Vorobyova, Liubov N Grushevskaya, Maria S Sergeeva, Dmitry N Kuznetsov and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Grigory V MokrovDepartment of Medicinal Chemistry, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.ORCID 0000-0003-2617-0334
Svetlana A LitvinovaDepartment of Neuropsychopharmacology, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.ORCID 0000-0001-9139-2334
Valentina E BiryukovaDepartment of Medicinal Chemistry, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.ORCID 0009-0000-9586-6971
Tatiana A VoroninaDepartment of Neuropsychopharmacology, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.
Sergey V ShorunovDepartment of Medicinal Chemistry, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.ORCID 0009-0009-6943-0440
Alexey G RebekoDepartment of Medicinal Chemistry, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.
Tatiana Yu VorobyovaDepartment of Medicinal Chemistry, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.
Liubov N GrushevskayaLaboratory of Standardization and Quality Control, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.ORCID 0000-0002-3794-9661
Maria S SergeevaLaboratory of Standardization and Quality Control, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.ORCID 0000-0002-7155-6714
Dmitry N KuznetsovLaboratory of Standardization and Quality Control, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.
Oxana Yu KravtsovaPharmacokinetics Laboratory, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.
Ekaterina A NikitinaDepartment of Neuropsychopharmacology, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.
Natalia A GladyshevaDepartment of Neuropsychopharmacology, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.
Aliy K ZhanataevDepartment of Toxicology, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.ORCID 0000-0002-7673-8672
Andrey D DurnevDepartment of Toxicology, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.
Timofey V LosevGroup of Theoretical Chemistry, Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospekt 47, 119991 Moscow, Russia.
Ksenia M MalashkeevichGroup of Theoretical Chemistry, Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospekt 47, 119991 Moscow, Russia.
Michael G MedvedevGroup of Theoretical Chemistry, Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospekt 47, 119991 Moscow, Russia.ORCID 0000-0001-7070-4052
Marat M IslamovFaculty of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia.
Konstantin A LyssenkoFaculty of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia.ORCID 0000-0002-3500-1287
Vladimir L DorofeevLaboratory of Standardization and Quality Control, Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies, Baltiyskaya 8, 125315 Moscow, Russia.ORCID 0009-0004-3584-3742

Funding

The Ministry of Education and Science of the Russian Federation FGFG-2025-0010
6 · The paper itself

Abstract

The synthesis, purification, and comprehensive characterization of the

Indexed as

AnticonvulsantsOximesAnimalsIsomerismMolecular StructureStereoisomerismAnticonvulsantsOximes4-benzoylpyridine oximesanticonvulsant activityE/Z-isomerismGIZH-298oximes

Identifiers

PMID42280174
PMCPMC13258319

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.